US Broker Ratings

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Limited Upside Amid a Competitive Landscape

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector, is a key player in the medical devices industry. Headquartered in Hercules, California, this company boasts a market capitalization..

Revvity, Inc. (RVTY) Stock Analysis: A Compelling 15.53% Upside in the Healthcare Diagnostics Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, specifically in diagnostics and research, presents an intriguing opportunity for investors with its potential upside of 15.53% according to recent..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a Potential 18% Upside and Strong Buy Ratings

Bio-Techne Corporation (NASDAQ: TECH) stands as a prominent player in the biotechnology industry, offering a diverse array of life science reagents, instruments, and services. With its headquarters in Minneapolis, Minnesota,..

Stevanato Group S.p.A. (STVN): Analyst Consensus Highlights 32.12% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN) stands as a noteworthy contender in the healthcare sector, specializing in the design and manufacture of comprehensive solutions for the biopharmaceutical and healthcare industries. With..

Haleon plc (HLN) Stock Analysis: Analysts See a 28.73% Upside for This Healthcare Giant

Haleon plc (HLN), a United Kingdom-based leader in the healthcare sector, has been capturing investor attention with its robust portfolio of consumer healthcare products. With a market capitalization of $40.34..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 111.76% Potential Upside in the Biotech Sector

Insmed Incorporated (NASDAQ: INSM) stands out in the biotechnology sector with its promising pipeline of therapies targeting serious and rare diseases. With a market capitalization of $20.42 billion, this healthcare..

West Pharmaceutical Services (WST) Stock Analysis: A 12% Upside Potential Amid Robust Revenue Growth

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a stalwart in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $22.22 billion, this..

Option Care Health, Inc. (OPCH) Stock Analysis: 42% Potential Upside Beckons Investors

Option Care Health, Inc. (NASDAQ: OPCH) stands at the forefront of the healthcare sector, particularly within the medical care facilities industry, offering a compelling investment opportunity for those eyeing the..

Merck & Co., Inc. (MRK) Stock Analysis: Evaluating a 7.41% Upside Potential Amid Strong Buy Ratings

Merck & Co., Inc. (NYSE: MRK) stands as a cornerstone in the healthcare sector, with a commanding market capitalization of $298.33 billion. Renowned for its robust portfolio in pharmaceuticals and..

DexCom, Inc. (DXCM): Investor Outlook Reveals 13.92% Potential Upside in Continuous Glucose Monitoring Market

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector specializing in medical devices, continues to command attention with its cutting-edge continuous glucose monitoring (CGM) systems. From its headquarters in..

Quest Diagnostics (DGX) Stock Analysis: Strong Upside Potential with Analyst Consensus

Investors seeking a solid opportunity in the healthcare sector might want to consider Quest Diagnostics Incorporated (NYSE: DGX), a leading player in the diagnostics and research industry. With a market..

Intuitive Surgical, Inc. (ISRG) Stock Report: Analyzing the 33.93% Potential Upside with Strong Buy Ratings

Intuitive Surgical, Inc. (NASDAQ: ISRG) stands as a formidable player in the medical instruments and supplies industry, with a market capitalization of $149.48 billion. Based in Sunnyvale, California, Intuitive Surgical..

Globus Medical, Inc. (GMED) Stock Analysis: A 37.5% Potential Upside Captures Investor Attention

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, stands out with its robust market presence and promising growth prospects. With a market..

GSK plc (GSK) Stock Analysis: Evaluating a Strong 12.46% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth outlook. With a market capitalization of..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Biotech Powerhouse with a 36.60% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) is capturing investor attention in the healthcare sector with its ambitious approach to drug development and a significant potential upside of 36.60%. As a clinical-stage..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Promising Biotechnology Leader with 47% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player in the biotechnology sector, known for its pioneering work in ribonucleic acid interference (RNAi) therapeutics. With a market capitalization of..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Potential with a 3.15% Upside

Novartis AG (NYSE: NVS), a Swiss pharmaceutical giant, commands a formidable presence in the healthcare sector, specifically within the drug manufacturing industry. As one of the leading players in the..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 35% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector as a formidable player in the medical care facilities industry, boasting a market capitalization of $10.32 billion. Investors are..

Repligen Corporation (RGEN) Stock Analysis: Unlocking a 43.98% Upside in Bioprocessing Innovation

Investors with a keen interest in the healthcare sector’s innovative frontier may find Repligen Corporation (NASDAQ: RGEN) a compelling prospect. With a market capitalization of $6.9 billion, Repligen stands as..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds